Selected research
Industry Growth & Trends
Global Phage Display Service Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Phage Display Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Phage Display Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Phage Display Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Phage Display Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Phage Display Service market include Creative Biogene, Creative Biolabs, ProteoGenix, CUSABIO, Diaclone, Biomolecular Discovery Services, Charles River, GenScript and Synbio Technologies, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Phage Display Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Phage Display Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Phage Display Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Phage Display Service.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Phage Display Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Phage Display Service Market by Company
Creative Biogene
Creative Biolabs
ProteoGenix
CUSABIO
Diaclone
Biomolecular Discovery Services
Charles River
GenScript
Synbio Technologies
Creative Peptides
ProImmune
Absolute Antibody
Iontas
LakePharma
KMD Bioscience
NeoClone
Pepscan
Abzena
ChemPartner
Creative Proteomics
Yntoab
Diane biological
Biosynth
Zoonbio Biotechnology
Abiocenter
Phage Display Service Segment by Type
cDNA Library
Antibody Library
Protein Library
Random Peptide Library
Phage Display Service Segment by Application
Immunotherapy
Drug Discovery
Functional Genomics
Others
Phage Display Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Phage Display Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Phage Display Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Phage Display Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Phage Display Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- cDNA Library
- Antibody Library
- Protein Library
- Random Peptide Library
Applications
- Immunotherapy
- Drug Discovery
- Functional Genomics
- Others
Companies covered
- Creative Biogene
- Creative Biolabs
- ProteoGenix
- CUSABIO
- Diaclone
- Biomolecular Discovery Services
- Charles River
- GenScript
- Synbio Technologies
- Creative Peptides
- ProImmune
- Absolute Antibody
- Iontas
- LakePharma
- KMD Bioscience
- NeoClone
- Pepscan
- Abzena
- ChemPartner
- Creative Proteomics
- Yntoab
- Diane biological
- Biosynth
- Zoonbio Biotechnology
- Abiocenter
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Phage Display Service Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Phage Display Service Market Size by Region (2021-2032)
- 1.4.1 Global Phage Display Service Market Size by Region (2021-2026)
- 1.4.2 Global Phage Display Service Market Size by Region (2027-2032)
- 1.5 Key Regions Phage Display Service Market Size (2021-2032)
- 1.5.1 North America Phage Display Service Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Phage Display Service Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Phage Display Service Market Size Growth Rate (2021-2032)
- 1.5.4 South America Phage Display Service Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Phage Display Service Market Size Growth Rate (2021-2032)
2 Phage Display Service Market by Type
- 2.1 Type Introduction
- 2.1.1 cDNA Library
- 2.1.2 Antibody Library
- 2.1.3 Protein Library
- 2.1.4 Random Peptide Library
- 2.2 Global Phage Display Service Market Size by Type
- 2.2.1 Global Phage Display Service Market Size Overview by Type (2021-2032)
- 2.2.2 Global Phage Display Service Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Phage Display Service Market Size Forecasted by Type (2027-2032)
- 2.3 Global Phage Display Service Market Size by Regions
- 2.3.1 North America Phage Display Service Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Phage Display Service Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Phage Display Service Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Phage Display Service Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Phage Display Service Market Size Breakdown by Type (2021-2026)
3 Phage Display Service Market by Application
- 3.1 Type Introduction
- 3.1.1 Immunotherapy
- 3.1.2 Drug Discovery
- 3.1.3 Functional Genomics
- 3.1.4 Others
- 3.2 Global Phage Display Service Market Size by Application
- 3.2.1 Global Phage Display Service Market Size Overview by Application (2021-2032)
- 3.2.2 Global Phage Display Service Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Phage Display Service Market Size Forecasted by Application (2027-2032)
- 3.3 Global Phage Display Service Market Size by Regions
- 3.3.1 North America Phage Display Service Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Phage Display Service Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Phage Display Service Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Phage Display Service Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Phage Display Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Phage Display Service Industry Trends
- 4.2 Phage Display Service Industry Drivers
- 4.3 Phage Display Service Industry Opportunities and Challenges
- 4.4 Phage Display Service Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Phage Display Service Revenue (2021-2026)
- 5.2 Global Phage Display Service Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Phage Display Service Key Company Headquarters & Area Served
- 5.4 Global Phage Display Service Company, Product Type & Application
- 5.5 Global Phage Display Service Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Phage Display Service Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Phage Display Service Players Market Share by Revenue in 2025
- 5.6.3 2025 Phage Display Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Creative Biogene
- 6.1.1 Creative Biogene Company Information
- 6.1.2 Creative Biogene Business Overview
- 6.1.3 Creative Biogene Phage Display Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Creative Biogene Phage Display Service Product Portfolio
- 6.1.5 Creative Biogene Recent Developments
- 6.2 Creative Biolabs
- 6.2.1 Creative Biolabs Company Information
- 6.2.2 Creative Biolabs Business Overview
- 6.2.3 Creative Biolabs Phage Display Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Creative Biolabs Phage Display Service Product Portfolio
- 6.2.5 Creative Biolabs Recent Developments
- 6.3 ProteoGenix
- 6.3.1 ProteoGenix Company Information
- 6.3.2 ProteoGenix Business Overview
- 6.3.3 ProteoGenix Phage Display Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 ProteoGenix Phage Display Service Product Portfolio
- 6.3.5 ProteoGenix Recent Developments
- 6.4 CUSABIO
- 6.4.1 CUSABIO Company Information
- 6.4.2 CUSABIO Business Overview
- 6.4.3 CUSABIO Phage Display Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 CUSABIO Phage Display Service Product Portfolio
- 6.4.5 CUSABIO Recent Developments
- 6.5 Diaclone
- 6.5.1 Diaclone Company Information
- 6.5.2 Diaclone Business Overview
- 6.5.3 Diaclone Phage Display Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Diaclone Phage Display Service Product Portfolio
- 6.5.5 Diaclone Recent Developments
- 6.6 Biomolecular Discovery Services
- 6.6.1 Biomolecular Discovery Services Company Information
- 6.6.2 Biomolecular Discovery Services Business Overview
- 6.6.3 Biomolecular Discovery Services Phage Display Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Biomolecular Discovery Services Phage Display Service Product Portfolio
- 6.6.5 Biomolecular Discovery Services Recent Developments
- 6.7 Charles River
- 6.7.1 Charles River Company Information
- 6.7.2 Charles River Business Overview
- 6.7.3 Charles River Phage Display Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Charles River Phage Display Service Product Portfolio
- 6.7.5 Charles River Recent Developments
- 6.8 GenScript
- 6.8.1 GenScript Company Information
- 6.8.2 GenScript Business Overview
- 6.8.3 GenScript Phage Display Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 GenScript Phage Display Service Product Portfolio
- 6.8.5 GenScript Recent Developments
- 6.9 Synbio Technologies
- 6.9.1 Synbio Technologies Company Information
- 6.9.2 Synbio Technologies Business Overview
- 6.9.3 Synbio Technologies Phage Display Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Synbio Technologies Phage Display Service Product Portfolio
- 6.9.5 Synbio Technologies Recent Developments
- 6.10 Creative Peptides
- 6.10.1 Creative Peptides Company Information
- 6.10.2 Creative Peptides Business Overview
- 6.10.3 Creative Peptides Phage Display Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Creative Peptides Phage Display Service Product Portfolio
- 6.10.5 Creative Peptides Recent Developments
- 6.11 ProImmune
- 6.11.1 ProImmune Company Information
- 6.11.2 ProImmune Business Overview
- 6.11.3 ProImmune Phage Display Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 ProImmune Phage Display Service Product Portfolio
- 6.11.5 ProImmune Recent Developments
- 6.12 Absolute Antibody
- 6.12.1 Absolute Antibody Company Information
- 6.12.2 Absolute Antibody Business Overview
- 6.12.3 Absolute Antibody Phage Display Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Absolute Antibody Phage Display Service Product Portfolio
- 6.12.5 Absolute Antibody Recent Developments
- 6.13 Iontas
- 6.13.1 Iontas Company Information
- 6.13.2 Iontas Business Overview
- 6.13.3 Iontas Phage Display Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Iontas Phage Display Service Product Portfolio
- 6.13.5 Iontas Recent Developments
- 6.14 LakePharma
- 6.14.1 LakePharma Company Information
- 6.14.2 LakePharma Business Overview
- 6.14.3 LakePharma Phage Display Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 LakePharma Phage Display Service Product Portfolio
- 6.14.5 LakePharma Recent Developments
- 6.15 KMD Bioscience
- 6.15.1 KMD Bioscience Company Information
- 6.15.2 KMD Bioscience Business Overview
- 6.15.3 KMD Bioscience Phage Display Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 KMD Bioscience Phage Display Service Product Portfolio
- 6.15.5 KMD Bioscience Recent Developments
- 6.16 NeoClone
- 6.16.1 NeoClone Company Information
- 6.16.2 NeoClone Business Overview
- 6.16.3 NeoClone Phage Display Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 NeoClone Phage Display Service Product Portfolio
- 6.16.5 NeoClone Recent Developments
- 6.17 Pepscan
- 6.17.1 Pepscan Company Information
- 6.17.2 Pepscan Business Overview
- 6.17.3 Pepscan Phage Display Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Pepscan Phage Display Service Product Portfolio
- 6.17.5 Pepscan Recent Developments
- 6.18 Abzena
- 6.18.1 Abzena Company Information
- 6.18.2 Abzena Business Overview
- 6.18.3 Abzena Phage Display Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Abzena Phage Display Service Product Portfolio
- 6.18.5 Abzena Recent Developments
- 6.19 ChemPartner
- 6.19.1 ChemPartner Company Information
- 6.19.2 ChemPartner Business Overview
- 6.19.3 ChemPartner Phage Display Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 ChemPartner Phage Display Service Product Portfolio
- 6.19.5 ChemPartner Recent Developments
- 6.20 Creative Proteomics
- 6.20.1 Creative Proteomics Company Information
- 6.20.2 Creative Proteomics Business Overview
- 6.20.3 Creative Proteomics Phage Display Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.20.4 Creative Proteomics Phage Display Service Product Portfolio
- 6.20.5 Creative Proteomics Recent Developments
- 6.21 Yntoab
- 6.21.1 Yntoab Company Information
- 6.21.2 Yntoab Business Overview
- 6.21.3 Yntoab Phage Display Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.21.4 Yntoab Phage Display Service Product Portfolio
- 6.21.5 Yntoab Recent Developments
- 6.22 Diane biological
- 6.22.1 Diane biological Company Information
- 6.22.2 Diane biological Business Overview
- 6.22.3 Diane biological Phage Display Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.22.4 Diane biological Phage Display Service Product Portfolio
- 6.22.5 Diane biological Recent Developments
- 6.23 Biosynth
- 6.23.1 Biosynth Company Information
- 6.23.2 Biosynth Business Overview
- 6.23.3 Biosynth Phage Display Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.23.4 Biosynth Phage Display Service Product Portfolio
- 6.23.5 Biosynth Recent Developments
- 6.24 Zoonbio Biotechnology
- 6.24.1 Zoonbio Biotechnology Company Information
- 6.24.2 Zoonbio Biotechnology Business Overview
- 6.24.3 Zoonbio Biotechnology Phage Display Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.24.4 Zoonbio Biotechnology Phage Display Service Product Portfolio
- 6.24.5 Zoonbio Biotechnology Recent Developments
- 6.25 Abiocenter
- 6.25.1 Abiocenter Company Information
- 6.25.2 Abiocenter Business Overview
- 6.25.3 Abiocenter Phage Display Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.25.4 Abiocenter Phage Display Service Product Portfolio
- 6.25.5 Abiocenter Recent Developments
7 North America
- 7.1 North America Phage Display Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Phage Display Service Market Size by Country (2021-2026)
- 7.3 North America Phage Display Service Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Phage Display Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Phage Display Service Market Size by Country (2021-2026)
- 8.3 Europe Phage Display Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Phage Display Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Phage Display Service Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Phage Display Service Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Phage Display Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Phage Display Service Market Size by Country (2021-2026)
- 10.3 South America Phage Display Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Phage Display Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Phage Display Service Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Phage Display Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst